Secondary Prophylaxis of Gastrointestinal Bleeding in Cirrhotic Patients Using THALIDOMIDE

NCT00787436 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Gastrointestinal Hemorrhage
Portal Hypertension

Interventions

DRUG: Thalidomide

Sponsor

The Cleveland Clinic

Collaborators

[object Object]